INVESTIGATION OF CYTOKINE PROFILE IN PATIENTS WITH REACTIVE ARTHRITIS
https://doi.org/10.15789/1563-0625-2008-2-3-167-172
Abstract
Abstract. Pathogenesis of reactive arthritis (ReA) is not clear yet. Several trials suggest that increased production of proinflammatory cytokines is responsible for development of arthritis in ReA, while other studies report that Th1 cytokine response in ReA is impaired in favor of Th2 response. The aim of our study was to investigate serum levels of cytokines IL-1β, IL-4, IL-6, TNFα, IFNγ and IL-1Ra in the patients with ReA of different etiology, as compared with infection-related arthritis. The results of our study had demonstrated that serum levels of IL-1β and TNFα in the patients with ReA were significantly higher, whereas IL-1Ra, IL-4, IL-6 proved to be significantly lower than in healthy controls. Serum levels of IL-6 were significantly higher in patients with chronic ReA, as compared to the cases of acute and recurrent ReA. No significant differences in cytokine profiles were found between the patients with ReA, and the persons with infection-related arthritis. The data obtained are, generally, suggestive for proinflammatory Th1 cytokine profile in ReA patients studied, this confirming the mostly assumed pathogenetic hypothesis for reactive arthritis where an underlying cytokine imbalance is suggested. (Med. Immunol., 2008, vol. 10, N 2-3, pp 167-172).
About the Authors
T. V. GaponovaRussian Federation
A. M. Lila
Russian Federation
T. G. Shemerovskaya
Russian Federation
G. A. Zakharova
Russian Federation
T. N. Maslyaeva
Russian Federation
References
1. Агабабова Э.Р., Бунчук Н.В., Шубин С.В. Критерии урогенных и энтерогенных реактивных артритов (проект) // Науч.-практ. ревматология. – 2003. – № 3. – С. 82-83.
2. Лила А.М. Реактивные артриты // Клиническая ревматология: руководство для врачей / Под ред. В.И. Мазурова. – СПб.: Фолиант, 2005. – С. 143-164.
3. Насонов Е.Л. Реактивные артриты // Клинические рекомендации. Ревматология / Под ред. Е.Л. Насонова. – М.: ГЭОТАР-Медиа, 2006. – С. 86-91.
4. Bas S., Kvein T.K., Buchs N., Fulpius T., Gabay C. Lower level of synovial fluid interferon-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamidia trachomatis reactive arthritis // Rheumatology. – 2003. – Vol. 42, N 3. – Р. 461-467.
5. Braun J., Kingsley G., Van der Heijde D., Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for ReA. Results of discussion of a questionnaire prepared for the 4th International Workshop on ReA. Berlin, Germany, July 3-6, 1999 // J. Rheumatol. – 2000. – Vol. 27. – Р. 2185-2192.
6. Braun J., Yin Z., Spiller I., Siegert S., Rudwaleit M., Liu L., Radbruch A., Sieper J. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis // Arthritis Rheum. – 1999. – Vol. 42, N 10. – Р. 2039-2034.
7. Butrimiene I., Jarmalaite S., Ranceva J., Venalis A., Jasiuleviciute L., Zvirbliene A. Different cytokine profiles in patients with chronic and acute reactive arthritis // Rheumatology. – 2004. – Vol. 43, N 10. – Р. 1300-1304.
8. Gabay G. Interleukin-6 and chronic inflammation // Arthritis Research & Therapy. – 2006. – Vol. 8 (Suppl. 2). – Р. 1-6.
9. Kir veskari J., He Q., Holmström T., Leirisalo- Repo M., Wuorela M., Mertsola J., Granfors K. Modulation of peripheral blood mononuclear cell activation status during Salmonella-triggered reactive arthritis // Arthritis Rheum. – 1999. – Vol. 42, N 10. – Р. 2045-2054.
10. Kohnke S.J. Reactive Arthritis. A Clinical Approach // Orthopaedic Nursing. – 2004. – Vol. 23, N 4. – P. 274-280.
11. Meador R., Hsia E., Kitumnuaypong T., Schumacher H.R. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis // Clin. Exp. Rheumatol. – 2002. – Vol. 20, N 6 (Suppl. 28). – Р. 130-134.
12. Penttinen M.A., Holmberg C.I., Sistonen L., Granfors K. HLA-B27 modulates nuclear factor kB Activation in human monocytic cells exposed to lipopolysaccharide // Arthritis Rheum. – 2002. – Vol. 46, N 8. – Р. 2172-2180.
13. Penttinen M.A., Ekman P., Granfors K. Non-Antigen Presenting Effects of HLA-B27 // Current Molecular Medicine. – 2004. – Vol. 4, N 1. – Р. 41-49.
14. Rih l M., Gu J., Baeten D., Märker-Hermann E., Goodall J.C., Gaston J.S.H., Kuipers J.G., Zeidler H. Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor α and interferon γ // Ann. Rheum. Dis. – 2004. – Vol. 63, N 12. – Р. 1673-1676.
15. Sibilia J., Libmach F-X. Reactive arthritis or chronic infectious arthritis? // Ann. Rheum. Dis. – 2002. – Vol. 61, N 7. – Р. 580-587.
16. Van der Bosch F., Kruithof E., Beaten D., Herssens A., Keyser F., Mielants H., Veys E.M. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (Infliximab) versus placebo in active spondyloarthropathy // Arthritis Rheum. – 2002. – Vol. 46, N 3. – Р. 755-765.
17. Yin Z., Braun J., Neure L., Wu P., Liu L., Eggens U., Sieper J. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis // Arthritis Rheum. – 1997. – Vol. 40, N 10. – Р. 1788-1797.
Review
For citations:
Gaponova T.V., Lila A.M., Shemerovskaya T.G., Zakharova G.A., Maslyaeva T.N. INVESTIGATION OF CYTOKINE PROFILE IN PATIENTS WITH REACTIVE ARTHRITIS. Medical Immunology (Russia). 2008;10(2-3):167-172. (In Russ.) https://doi.org/10.15789/1563-0625-2008-2-3-167-172